O'Brien Federica F. 4
4 · TELA Bio, Inc. · Filed May 30, 2025
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
O'Brien Federica F.
Director
Transactions
- Award
Common Stock
[F1]2025-05-28+7,950→ 18,470 total - Award
Stock Option (Right to Buy)
[F2]2025-05-28+11,700→ 11,700 totalExercise: $1.39Exp: 2035-05-28→ Common Stock (11,700 underlying)
Footnotes (2)
- [F1]These restricted stock units vest on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
- [F2]The option vests on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
Signature
/s/ Megan Smeykal, Attorney-in-fact|2025-05-30